Clinical Focus

  • Anesthesia

Academic Appointments

Administrative Appointments

  • Chief Medical Officer, University Healthcare Alliance (2014 - Present)
  • Associate Chief Medical Officer, Stanford Health Care (2011 - Present)
  • Co-Director, Clinical Effectiveness Leadership Program (CELT) (2014 - Present)
  • Senior Advisor, WellMD Center (2017 - Present)
  • Interim Director, WellMD Center (2015 - 2017)
  • Affiliate, Freeman Spogli Institute (2014 - Present)
  • Chief of Staff, Stanford Health Care (2008 - 2011)
  • Board Member, Stanford Health Care Board of Directors (2008 - 2011)

Professional Education

  • Medical Education:Univ Of Chicago - Registrar (1981) IL
  • Board Certification: Anesthesia, American Board of Anesthesiology (1988)
  • Residency:Stanford University School of Medicine (1986) CA
  • Board Certification: Internal Medicine, American Board of Internal Medicine (1984)
  • Residency:Stanford University School of Medicine (1984) CA
  • Internship:Stanford University School of Medicine (1982) CA



All Publications

  • What Do We Mean by Physician Wellness? A Systematic Review of Its Definition and Measurement ACADEMIC PSYCHIATRY Brady, K. S., Trockel, M. T., Khan, C. T., Raj, K. S., Murphy, M., Bohman, B., Frank, E., Louie, A. K., Roberts, L. 2018; 42 (1): 94–108


    Physician wellness (well-being) is recognized for its intrinsic importance and impact on patient care, but it is a construct that lacks conceptual clarity. The authors conducted a systematic review to characterize the conceptualization of physician wellness in the literature by synthesizing definitions and measures used to operationalize the construct.A total of 3057 references identified from PubMed, Web of Science, and a manual reference check were reviewed for studies that quantitatively assessed the "wellness" or "well-being" of physicians. Definitions of physician wellness were thematically synthesized. Measures of physician wellness were classified based on their dimensional, contextual, and valence attributes, and changes in the operationalization of physician wellness were assessed over time (1989-2015).Only 14% of included papers (11/78) explicitly defined physician wellness. At least one measure of mental, social, physical, and integrated well-being was present in 89, 50, 49, and 37% of papers, respectively. The number of papers operationalizing physician wellness using integrated, general-life well-being measures (e.g., meaning in life) increased [X 2 = 5.08, p = 0.02] over time. Changes in measurement across mental, physical, and social domains remained stable over time.Conceptualizations of physician wellness varied widely, with greatest emphasis on negative moods/emotions (e.g., burnout). Clarity and consensus regarding the conceptual definition of physician wellness is needed to advance the development of valid and reliable physician wellness measures, improve the consistency by which the construct is operationalized, and increase comparability of findings across studies. To guide future physician wellness assessments and interventions, the authors propose a holistic definition.

    View details for DOI 10.1007/s40596-017-0781-6

    View details for Web of Science ID 000424047400015

    View details for PubMedID 28913621

  • A Brief Instrument to Assess Both Burnout and Professional Fulfillment in Physicians: Reliability and Validity, Including Correlation with Self-Reported Medical Errors, in a Sample of Resident and Practicing Physicians. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry Trockel, M., Bohman, B., Lesure, E., Hamidi, M. S., Welle, D., Roberts, L., Shanafelt, T. 2017


    The objective of this study was to evaluate the performance of the Professional Fulfillment Index (PFI), a 16-item instrument to assess physicians' professional fulfillment and burnout, designed for sensitivity to change attributable to interventions or other factors affecting physician well-being.A sample of 250 physicians completed the PFI, a measure of self-reported medical errors, and previously validated measures including the Maslach Burnout Inventory (MBI), a one-item burnout measure, the World Health Organization's abbreviated quality of life assessment (WHOQOL-BREF), and PROMIS short-form depression, anxiety, and sleep-related impairment scales. Between 2 and 3 weeks later, 227 (91%) repeated the PFI and the sleep-related impairment scale.Principal components analysis justified PFI subscales for professional fulfillment, work exhaustion, and interpersonal disengagement. Test-retest reliability estimates were 0.82 for professional fulfillment (α = 0.91), 0.80 for work exhaustion (α = 0.86), 0.71 for interpersonal disengagement (α = 0.92), and 0.80 for overall burnout (α = 0.92). PFI burnout measures correlated highly (r ≥ 0.50) with their closest related MBI equivalents. Cohen's d effect size differences in self-reported medical errors for high versus low burnout classified using the PFI and the MBI were 0.55 and 0.44, respectively. PFI scales correlated in expected directions with sleep-related impairment, depression, anxiety, and WHOQOL-BREF scores. PFI scales demonstrated sufficient sensitivity to detect expected effects of a two-point (range 8-40) change in sleep-related impairment.PFI scales have good performance characteristics including sensitivity to change and offer a novel contribution by assessing professional fulfillment in addition to burnout.

    View details for DOI 10.1007/s40596-017-0849-3

    View details for PubMedID 29196982

  • Novel Metrics for Improving Professional Fulfillment. Annals of internal medicine DiAngi, Y. T., Lee, T. C., Sinsky, C. A., Bohman, B. D., Sharp, C. D. 2017; 167 (10): 740–41

    View details for DOI 10.7326/M17-0658

    View details for PubMedID 29052698


    View details for Web of Science ID A1985AKL4700039

    View details for PubMedID 18749668

    View details for PubMedCentralID PMC1305963

  • A PATIENT WITH POLYURIA AND HYPONATREMIA KIDNEY INTERNATIONAL Jamison, R. L., Bohman, B., Marshall, W. H., Berns, A., Coe, F., Donohoe, J., Glynn, J., Muldowney, F., Vinay, P., Bushinsky, D., McCoy, C. E., Madias, N. E., Harrington, J. T., Cohen, J. J. 1983; 24 (2): 256-267

    View details for Web of Science ID A1983RF32200016

    View details for PubMedID 6632525



    The apparent rate of acetylcholine (ACh) turnover and levels of ACh and choline (Ch) in whole mouse brain were examined 30 min following i.p. injection of 25 mg/kg of three tricyclic antidepressants (TAD's): amitriptyline, chlorimipramine, and imipramine. The effects of these agents on high affinity choline uptake (HACU), a rate-limiting, regulatory step in ACh synthesis, were also examined. All three TAD's inhibited ACh turnover (by 27-40%), increased Ch levels (by 33-37%), and inhibited HACU (IC50's from 1.7 - 6.8 X 10(-5) M). Two of the three drugs produced significant decreases in ACh levels. It is concluded that these agents possess anticholinergic activity which is independent of their previously demonstrated muscarinic receptor blocking capabilities. As substantial evidence has accumulated linking increased cholinergic function with depression, it is speculated that this additional anticholinergic activity may contribute to the clinical efficacy of the TAD's.

    View details for Web of Science ID A1982NE53200007

    View details for PubMedID 7073400

  • Effects of tricyclic antidepressants on muscarinic cholinergic receptor binding in rat brain Life Sciences Bohman, B., Halaris, A., Karbowski, M. 1981; 29: 29